Search
Relmada Therapeutics Inc
RLMDAdd to Watchlist
4.120USD
-0.080-1.90%
Close 09-18 16:00（ET）
438.41MMarket Cap
LossP/E TTM
RLMD Financials
See Relmada Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
438.41M
Dividend TTM
0.00
P/E TTM
-3.75
EPS TTM
-1.10
Revenue
--
Net Profit
-79.98M
ROE
-48.83%
ROA
-44.77%
Relmada Therapeutics Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
-0.11/-0.20
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its current assets were 93.98M, with a year-on-year change of 105.22.
What are the total assets of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its total assets of Relmada Therapeutics Inc were 94.00M, with a year-on-year change of 105.17.
What are the total liabilities of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its total liabilities of Relmada Therapeutics Inc were 7.49M, with a year-on-year change of -27.24.
What is the total equity of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its total equity of Relmada Therapeutics Inc was 86.51M, with a year-on-year change of 143.55.
What is the net operating income of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its net operating income of Relmada Therapeutics Inc was -59.10M, with a year-on-year change of 29.55.
What is the net investment of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its net investment of Relmada Therapeutics Inc was -48.14M, with a year-on-year change of -193.36.
What is the net financing of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its net financing of Relmada Therapeutics Inc was 93.56M, with a year-on-year change of 232034.78.
What is the Earnings Per Share (EPS) of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.45, with a year-on-year change of 45.18.
What is the net income of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its net income was -57.39M, with a year-on-year change of 28.25.
What is the Return on Equity (ROE) of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -94.05, with a year-on-year change of 28.93.
What is the Return on Assets (ROA) of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -82.08, with a year-on-year change of 26.43.
What is the operating profit of Relmada Therapeutics Inc?
According to Relmada Therapeutics Inc's FY2025 earnings report, its operating profit was -59.10M, with a year-on-year change of 29.55.